Antibiotic‐associated disruption of microbiota composition and function in cirrhosis is restored by fecal transplant
File(s)
Accepted version
Author(s)
Mullish, BH
McDonald, Julie AK
Thursz, Mark R
Marchesi, Julian R
Type
Journal Article
Date Issued
2018-09-01
Date Acceptance
2018-05-01
Citation
Hepatology, 2018, 68 (3), pp.1205-1205
ISSN
0270-9139
Publisher
Wiley
Start Page
1205
End Page
1205
Journal / Book Title
Hepatology
Volume
68
Issue
3
Copyright Statement
© 2018 by the American Association for the Study of Liver Diseases. This is the pre-peer reviewed version of the following article, which has been published in final form at https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.30090.
Sponsor
Medical Research Council
Medical Research Council (MRC)
Identifier
https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.30090
Grant Number
MR/R00875/1
MR/R000875/1
Subjects
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
Anti-Bacterial Agents
Fecal Microbiota Transplantation
Gastrointestinal Microbiome
Humans
Liver Cirrhosis
Microbiota
Humans
Liver Cirrhosis
Anti-Bacterial Agents
Microbiota
Gastrointestinal Microbiome
Fecal Microbiota Transplantation
1103 Clinical Sciences
1101 Medical Biochemistry and Metabolomics
Gastroenterology & Hepatology
Publication Status
Published
Date Publish Online
2018-05-18